This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Will be exhibiting at ESCMID Global 2026 and presenting results of a novel quality assessment product to enable full-process quality management of molecular assays to detect an RNA-based virus. Microbix Biosystems Inc. shares T.MBX are trading unchanged at $0.25.